Bristol-Myers Squibb CompanyBMYNYSE
LOADING
|||
BMYCash Flow Performance
Above historical average, strong compound growth.
Left:
|||
Cash generated from core business operations
Latest
$15.19B
↑ 55% above average
Average (9y)
$9.81B
Historical baseline
Range
High:$16.21B
Low:$2.10B
CAGR
+24.6%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $15.19B | +9.6% |
| 2023 | $13.86B | +6.1% |
| 2022 | $13.07B | -19.4% |
| 2021 | $16.21B | +15.3% |
| 2020 | $14.05B | +71.2% |
| 2019 | $8.21B | +16.2% |
| 2018 | $7.07B | +34.0% |
| 2017 | $5.28B | +72.5% |
| 2016 | $3.06B | +45.3% |
| 2015 | $2.10B | - |